129 related articles for article (PubMed ID: 2438229)
1. Pituitary and testicular hormonal function after treatment for germ cell tumours.
Bosl GJ; Bajorunas D
Int J Androl; 1987 Feb; 10(1):381-4. PubMed ID: 2438229
[TBL] [Abstract][Full Text] [Related]
2. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of disseminated germ cell tumors of the testis].
Tiuliandin SA
Sov Med; 1987; (11):78-81. PubMed ID: 2451298
[No Abstract] [Full Text] [Related]
4. Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Bosl GJ; Leitner SP; Atlas SA; Sealey JE; Preibisz JJ; Scheiner E
Int J Androl; 1987 Feb; 10(1):353-7. PubMed ID: 2438226
[TBL] [Abstract][Full Text] [Related]
5. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
6. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
Madej G; Gigier A; Siedlecki P; Pieńkowski T
Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
[No Abstract] [Full Text] [Related]
8. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
Srougi M; Simon SD; de Góes GM
AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
[No Abstract] [Full Text] [Related]
9. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
10. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
Tiuliandin SA
Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
[TBL] [Abstract][Full Text] [Related]
11. Fertility after chemotherapy for male and female germ cell tumours.
Rustin GJ; Pektasides D; Bagshawe KD; Newlands ES; Begent RH
Int J Androl; 1987 Feb; 10(1):389-92. PubMed ID: 2438231
[TBL] [Abstract][Full Text] [Related]
12. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
Vugrin D; Whitmore WF; Golbey RB
J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
[TBL] [Abstract][Full Text] [Related]
13. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
14. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
Bassoulet J; Raoul Y; Garetta L
Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
Chiricuţă I; Ghilezan N
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
[No Abstract] [Full Text] [Related]
16. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
18. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Raghavan D; Levi J; Thomson D; Harvey V
Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
[No Abstract] [Full Text] [Related]
19. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
20. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
